Clinical Trial Update: Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial in healthy adults evaluating tolerability of a recombinant DNA HIV-1 vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 recombinant DNA vaccine

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Human Immunodeficiency Virus, HIV Infections | Phase 1 | Status: COMPLETED